Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.
2.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
3.

Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.

Woods VD, Montgomery SB, Herring RP, Gardner RW, Stokols D.

J Natl Med Assoc. 2006 Apr;98(4):492-504. Review.

4.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

5.

American Cancer Society guideline for the early detection of prostate cancer: update 2010.

Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA; American Cancer Society Prostate Cancer Advisory Committee.

CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3. Review.

6.

Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.

Hewitson P, Austoker J.

BJU Int. 2005 Apr;95 Suppl 3:16-32. Review. No abstract available.

PMID:
15844284
7.

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.

Lim LS, Sherin K; ACPM Prevention Practice Committee.

Am J Prev Med. 2008 Feb;34(2):164-70. doi: 10.1016/j.amepre.2007.10.003. Review. Erratum in: Am J Prev Med. 2008 May;34(5):454.

PMID:
18201648
8.

Screening for prostate cancer: the current evidence and guidelines controversy.

Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R.

Can J Urol. 2011 Oct;18(5):5875-83. Review.

9.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
10.

Screening for prostate cancer: informing men about their options.

Mahon SM.

Clin J Oncol Nurs. 2005 Oct;9(5):625-7. Review. No abstract available.

PMID:
16235590
11.

Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.

Hayes JH, Barry MJ.

JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085. Review.

PMID:
24643604
12.

Managing the low-socioeconomic-status prostate cancer patient.

Rayford W.

J Natl Med Assoc. 2006 Apr;98(4):521-30. Review.

13.

Screening for prostate cancer: the debate continues.

Matrana MR, Atkinson B.

J Adv Pract Oncol. 2013 Jan;4(1):16-21. Review.

14.

Personalized risk communication for informed decision making about screening tests.

Giles K.

Clin J Oncol Nurs. 2015 Feb;19(1):118-9. doi: 10.1188/15.CJON.118-119. Review. No abstract available.

PMID:
25689659

Supplemental Content

Support Center